Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC has announced that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers. The lawsuit alleges violations of federal securities laws on behalf of investors who purchased Erasca securities between January 14, 2025, and April 26, 2026. The complaint claims that defendants made misleading statements and failed to disclose material facts, including that ERAS-0015's preclinical data was based on improper comparisons to Revolution Medicines, Inc. and that Erasca risked violating patent and trade secret protections. Investors who suffered losses are encouraged to join the case by August 10, 2026, to request appointment as lead plaintiff. The law firm represents investors on a contingency fee basis.